Three Red Cross Women Who Persevered: African American History Month
The American Red Cross has served our country for more than 135 years. In honor of African-American History Month, we wanted to spotlight three…
News
How to Recover from Night Shifts
Nurses are no strangers to the ill-effects of working night shifts. Aside from being physically draining, a graveyard schedule can also put them at…
New newborn screening for metabolic disorders
On Feb. 3, the U.S. Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare Lysosomal Storage…
FDA teething tablet warning
On Jan. 27, the U.S. Food and Drug Administration (FDA) warned that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and…
FDA, EPA releases fish consumption advice for specific groups
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) have released guidance for fish consumption; the guidelines are targeted to women…
FDA approves first drug for treating spinal muscular dystrophy
On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular…
FDA expands indication for continuous glucose monitoring system
On Dec. 20, the Food and Drug Administration (FDA) expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for…
FDA approves new treatment for advanced ovarian cancer
On Dec. 19, the Food and Drug Administration (FDA) approved Rubraca (rucaparib) to treat women with advanced ovarian cancer who have been treated with…
FDA issues warning about anesthesia/sedation use in young children and pregnant women
On Dec. 14, the Food and Drug Administration (FDA) released a safety communication warning that repeated or lengthy use of general anesthetic and sedation…
FDA approves new treatment for eczema
On Dec. 14, the Food and Drug Administration (FDA) approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema in patients 2 years of…
FDA grants to stimulate product development for rare diseases
On Oct. 17, the Food and Drug Administration (FDA) announced that it has awarded more than $23 million in research grants over the next…
FDA approvals—July 11-12, 2016
On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye…
Three Red Cross Women Who Persevered: African American History Month
The American Red Cross has served our country for more than 135 years. In honor of African-American History Month, we wanted to…
How to Recover from Night Shifts
Nurses are no strangers to the ill-effects of working night shifts. Aside from being physically draining, a graveyard schedule can also put…
New newborn screening for metabolic disorders
On Feb. 3, the U.S. Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare…
FDA teething tablet warning
On Jan. 27, the U.S. Food and Drug Administration (FDA) warned that homeopathic teething tablets containing belladonna pose an unnecessary risk to…
FDA, EPA releases fish consumption advice for specific groups
The Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) have released guidance for fish consumption; the guidelines are targeted…
FDA approves first drug for treating spinal muscular dystrophy
On Dec. 23, the Food and Drug Administration (FDA) approved Spinraza (nusinersen), the first drug approved to treat children and adults with…
FDA expands indication for continuous glucose monitoring system
On Dec. 20, the Food and Drug Administration (FDA) expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to…
FDA approves new treatment for advanced ovarian cancer
On Dec. 19, the Food and Drug Administration (FDA) approved Rubraca (rucaparib) to treat women with advanced ovarian cancer who have been…
FDA issues warning about anesthesia/sedation use in young children and pregnant women
On Dec. 14, the Food and Drug Administration (FDA) released a safety communication warning that repeated or lengthy use of general anesthetic…
FDA approves new treatment for eczema
On Dec. 14, the Food and Drug Administration (FDA) approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema in patients 2…
FDA grants to stimulate product development for rare diseases
On Oct. 17, the Food and Drug Administration (FDA) announced that it has awarded more than $23 million in research grants over…
FDA approvals—July 11-12, 2016
On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of…